Skip to content
New Options

You Deserve a Better Life

Have you or a loved one received a diagnosis of Peripheral Artery Disease (PAD) or Chronic Limb-Threatening Ischemia (CLTI)? PAD and CLTI are serious conditions that can threaten both life and limb.

Living with PAD that progresses to CLTI can be extremely challenging. Chronic leg pain and non-healing wounds are debilitating, and conventional treatments may no longer be effective, leaving amputation as the only option for end-stage patients.

It may be difficult to imagine life without the use of a limb that has been a part of you for so long. But there is hope – ask your doctor about the LimFlow System and take the first step towards a brighter tomorrow.

CLTI – the Most Severe Form of Peripheral Arterial Disease

CLTI Patient
3.8M Square
In the U.S. affected by Chronic Limb-Threatening Ischemia (CLTI) and the number continues to grow1
150K Square
Major lower extremity amputations in the U.S. annually2
4x Square
More likely to face major amputation if you are Black3
6th Square
Most expensive surgical procedure in the U.S. = Major Amputation4

Driven by high complication rates, length of stay, readmissions, and hospitalizations

About LimFlow Therapy

Before LimFlow


After LimFlow


The LimFlow system is a breakthrough treatment that can restore blood flow to your affected limb and give you a chance at a better future. With this groundbreaking solution, you can keep your limb and potentially avoid a lifetime of limitations.

Find a Doctor and Take Charge

Use our locator to find a doctor who is experienced using the LimFlow System to treat appropriate patients with late-stage CLTI

Site NameSite LocationPhysician
AtlanticareAtlantic City, NJNicholas Petruzzi
Atrium HealthCharlotte, NCGregory Stanley
Boston Medical CenterBoston, MAAlik Farber
Dartmouth – Hitchcock Medical CenterLebanon, NHRichard Powell
Jocelyn Beach
Hospital of the University of PennsylvaniaPhiladelphia, PAElizabeth Genovese
Icahn School of Medicine at Mount SinaiNew York, NYPrakash Krishnan
Massachusetts General HospitalBoston, MAAnahita Dua
Presbyterian Healthcare ServicesAlbuquerque, NMSteve Henao
Rush University Medical CenterChicago, ILSreekumar Madassery
The Cardiac and Vascular InstituteGainesville, FLArthur Lee
University Hospitals Cleveland Medical CenterCleveland, OHMehdi Shishehbor
UCSF Medical CenterSan Francisco, CAMichael Conte
Shant Vartanian
University of FloridaGainesville, FLBenjamin Jacobs
University of Massachusetts Chan Medical SchoolWorcester, MADouglas Jones
UT Southwestern Medical CenterDallas, TXMichael Siah
Vanderbilt University Medical CenterNashville, TNDaniel Clair
Washington UniversitySt. Louis, MOPatrick Geraghty
Weill Cornell MedicineNew York, NYBrian DeRubertis
Yale UniversityNew Haven, CTCassius Iyad Ochoa Chaar

Hear From Patients

Listen to the experiences of other patients who had lost hope until their doctor recommended treatment with the innovative LimFlow System.

  1. Yost ML. CLI US epidemiology supplement 2016. THE SAGE GROUP.
  2. Creager MA, Matsushita K, Arya S, Beckman JA, Duval S, Goodney PP, Gutierrez JAT, Kaufman JA, Joynt Maddox KE, Pollak AW, Pradhan AD, Whitsel LP. Reducing Nontraumatic Lower-Extremity Amputations by 20% by 2030: Time to Get to Our Feet: A Policy Statement From the American Heart Association. Circulation. 2021 Apr 27;143(17):e875-e891.
  3. Estimated U.S. hospital procedure Cost including stay (excluding LF system) based on cost estimates from clinical data collected in PROMISE II IDE Pivotal Study cross walked to corresponding cost data from Liberty 360 Economic Study Supplement and U.S. hospital CFO feedback.
  4. Yost ML. Cost-Benefit Analysis of Critical Limb Ischemia in the Era of the Affordable Care Act. 2014. Endovascular Today